Stimulation of rat mesangial cell thromboxane a2 receptors inhibits particulate but not soluble guanylyl cyclase

American Journal of Physiology

Volumn 270, Issue 1 PART 2, 1996, Pages

  Paul, Richard V ^a,b,c   Saxenhofer, Hermann ^a,b,c   Wackym, Pamela S ^a,b,c   Halushka, Perry V ^a,b,c  

^a MUSC Medical Center   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Guanosine 3 ,5 cyclic monophosphate; Natriuretic peptides; Nitroprusside; Radioligand

Indexed keywords

GUANYLATE CYCLASE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; ENZYME INHIBITION; GLOMERULOPATHY; MESANGIUM CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ATRIAL NATRIURETIC FACTOR; BINDING, COMPETITIVE; CYCLIC GMP; GLOMERULAR MESANGIUM; GUANYLATE CYCLASE; NITROPRUSSIDE; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RATS; RECEPTORS, THROMBOXANE; SOLUBILITY; THROMBOXANE A2;

EID: 0030050309     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.270.1.f31     Document Type: Article

References (36)

1. 2 receptor: molecular cloning, signal transduction, and intrarenal expression localization. J. Clin. Invest. 96: 657-664, 1995.
2. Appel, R. G. Growth inhibitory activity of atrial natriuretic factor in rat glomerular mesangial cells. FEES Lett. 238: 135138, 1988.
3. Brooker, G., J. F. Harper, W. L. Terasaki, and R. D. Moylan. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10: 1-33, 1979.
4. Bruggeman, L., E. Horigan, S. Horikoshi, P. Ray, and P. Klotman. Thromboxane stimulates synthesis of extracellular matrix proteins in vitro. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol.30): F488-F494, 1991.
5. Craven, P. A., M. F. Melhem, and F. R. deRubertis. Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney Int. 42: 937-946, 1992.
6. Craven, P., R. Studer, and F. deRubertis. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J. Clin. Invest. 311: 311-320, 1994.
7. Felsen, D., M. Loo, D. Marion, and E. D. Vaughan, Jr. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction. J. Urol. 144: 141- us, 1990.
8. Folger, W. H., P. V. Halushka, C. S. Wilcox, and N. J. Guzman. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets. Ear. J. Pharmacol. 227: 71-78, 1992.
9. Furci, L., D. J. Fitzgerald, and G. A. Fitzgerald. Heterogeneity of prostaglandin H2/thromboxane Aa receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J. Pharmacol. Exp. Ther. 258: 74-81, 1991.
10. Hall, S. E. Thromboxane A2 receptor antagonists. Med. Res. Rev. 11:503-579, 1991.
11. Halushka, P., D. Mais, and D. Saussy, Jr. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors. Federation Proc. 46: 149-153, 1987.
12. Haneda, M., R. Kikkawa, S. Maeda, M. Togawa, D. Koya, N. Horide, N. Kajiwara, and Y. Shigeta. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney Int. 40: 188-194, 1991.
13. Himmelstein, S., and P. Klotman. The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats. Am. J. Physiol. 257 (Renal Fluid Electrolyte Physiol.26): F190-F196, 1989.
14. Johnson, A., F. Lermioglu, U. Garg, R. Morgan-Boyd, and A. Hassid. A novel biological effect of atrial natriuretic hormone: inhibition of mesangial cell mitogenesis. Biochem. Biophys. Res. Commun. 152: 893- 897, 1988.
15. Lowry, O., N. Rosebrough, A. Farr, and R. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
16. Masuda, A., D. E. Mais, J. J. Oatis, and P. V. Halushka. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Biochem. Pharmacol. 42: 537-544, 1991.
17. Mené, P., G. Dubyak, H. Abboud, A. Scarpa, and M. Dünn. Phospholipase C activation by prostaglandins and thromboxane A'2 in cultured mesangial cells. Am. J. Physiol.255 (Renal Fluid Electrolyte Physiol. 24): F1059-F1069, 1988.
18. Morinelli, T.A., M. Naka,A. Masuda, J. J. Oatis,A. K. Okwu, D. E. Mais, D. J. Saussy, and P. V. Halushka. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Adv. Prostaglandin Thromboxane Leukotriene Res. 21A: 331-337, 1992.
19. Morinelli, T., J. Oatis, A. Okwu, D. Mais, P. Mayeux, A. Masuda, D. Knapp, and P. Halushka. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J. Pharmacol. Exp. Ther. 251: 557-562, 1989.
20. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
21. Nambi, P., M. Whitman, G. Gessner, N. Aiyar, and S. Crooke. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line. Proc. Natl.Acad. Sci. USA 83: 8492-8495, 1986.
22. Oehlenschlager, W., S. Kubalak, and M. Currie. A rapid and economical method of preparing radioiodinated cyclic nucleotide derivatives for use in radioimmunoassays. J. Immunoassay 11: 109-118, 1990.
23. Paul, R., M. Budisavljevic, P. Wackym, E. Everett, and J. Norris. Regulation of atrial peptide receptors in mesangial cells by growth factors. J. Biol. Chem. 268: 18205-18212, 1993.
24. Raychowdhury, M. K., M. Yukawa, L. J. Collins, S. H. McGrail, K. C. Kent, and J. A. Ware. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J. Biol. Chem. 269: 19256-19261, 1994.
25. Remuzzi, G., G. G. Fitz, and C. Patrono. Thromboxane synthesis and action within the kidney. Kidney Int. 41: 14831493, 1992.
26. Rinder, C., P. Halushka, M. Sens, and D. Ploth. Thromboxane Aa receptor blockade improves renal function and histopathology in the post-obstructive kidney. Kidney Int. 45: 185-192, 1994.
27. Rossini, M., A. Belloni, G. Remuzzi, and N. Perico. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation. Circulation 81: 161168,1990.
28. Spurney, R. F., P. Y. Fan, P. Ruiz, F. Sanfilippo, D. S. Pisetsky, and T. M. G off man. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int. 41: 973-982,1992.
29. Spurney, R., S. Mayros, D. Collins, P. Ruiz, P. Klotman, and T. Coffman. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats. Prostaglandins 39: 135-146, 1990.
30. Spurney, R. F., J. J. Onorato, F. J. Albers, and T. M. Coffman. Thromboxane binding and signal transduction in rat glomerular mesangial cells. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol.36): F467-F478, 1994.
31. Spurney, R. F., J. J. Onorato, P. Ruiz, D. S. Pisetsky, and T. M. Coffman. Characterization of glomerular thromboxane receptors in murine lupus nephritis. J. Pharmacol. Exp. Ther. 264: 584-590, 1993.
32. Stahl, R. A., F. Thaiss, U. Wenzel, W. Schoeppe, and U. Helmchen. A rat model of progressive chronic glomerular sclerosis: the role of thromboxane inhibition. J. Am. Soc. Nephrol. 2:1568-1577, 1992.
33. Studer, R. K., P. A. Craven, and F. R. deRubertis. Activation of protein kinase C reduces thromboxane receptors in glomeruli and mesangial cells. Kidney Int. 44: 58-64, 1993.
34. Terada, Y., K. Tomita, N. Yoshiyama, T. Shiigai, and F. Marumo. Leukotriene Ü4 inhibits atrial natriuretic factordependent cGMP production in rat glomerulus. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol.25): F95-F99, 1989.
35. Wilkes, B., J. Solomon, M. Maita, and P. Mento. Characterization of glomerular thromboxane receptor sites in the rat. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol.25): F1111-F1116, 1989.
36. Winquist, R. J., E. P. Faison, S. A. Waldman, K. Schwartz, F. Murad, and R. M. Rapoport. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc. Natl. Acad. Sci. USA 81: 7661-7664,1984.